A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: Impact on depression-related treatment charges-Reference-Cited by-同舟云学术

A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: Impact on depression-related treatment charges

Published:2004-01 Issue:1 Volume:26 Page:115-124
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

McLaughlin Trent P.,Eaddy Michael T.,Grudzinski Amy N.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Practice guideline for the treatment of patients with major depression;American Psychiatric Association;Working Group on Major Depressive Disorder,2003

2. What does treatment of depression really cost?;Croghan;Health Aff (Milwood),1998

3. The added costs of depression to medical care;Franco;PharmacoEconomics,1995

4. Depression: A neglected major illness;Greenberg;J Clin Psychiatry,1993

5. Depression in Primary Care: Detection, Diagnosis, and Treatment;Agency for Health Care Policy and Research,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness comparisons between antidepressant treatments in depression: Evidence from database analyses and prospective studies;Journal of Affective Disorders;2012-07

2. A Critical Review of Model-Based Economic Studies of Depression;PharmacoEconomics;2012-06

3. Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec: A Comparative Cost-Effectiveness Approach;Value in Health;2011-06

4. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population;Journal of Affective Disorders;2009-05

5. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis;Advances in Therapy;2009-03